Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.2 |
mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.077 | 0.2 |
mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.2 |